Stagnating sales and delayed rights issue adds to Zoono’s woes

Stagnating sales and delayed rights issue adds to Zoono’s woes
Zoono did it tough after covid induced boom. (Image: Getty)
Denise McNabb
A mounting stockpile of unsold product with looming expiry dates and the postponement of a non-renounceable rights issue due to undisclosed “external circumstances” are the latest woes for cash-strapped Australian securities exchange-listed New Zealand hand and sanitiser manufacturer Zoono Group.In its second quarterly report to December 2023, released Wednesday, the company acknowledged significant work needed to be done before it was cashflow positive and profitable.The group reported a $514,000 net cash deficit on operating activ...

More Markets

Advent International eyes NZ deals with Aussie outpost
Markets

Advent International eyes NZ deals with Aussie outpost

US private equity giant says NZ key market for growth.

These shares are 'priced for awful'
Markets

These shares are 'priced for awful'

Kathmandu, SkyCity and Fletcher shares are under pressure. Some are taking the plunge.

NZ sharemarket drifts lower
Markets Market close

NZ sharemarket drifts lower

The S&P/NZX 50 Index closed at 11,776.73, easing 12.65 points or 0.11%.

Graham Skellern 02 Jul 2024